Correlation Between Immunocore Holdings and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immunocore Holdings and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunocore Holdings and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunocore Holdings and Akero Therapeutics, you can compare the effects of market volatilities on Immunocore Holdings and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunocore Holdings with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunocore Holdings and Akero Therapeutics.
Diversification Opportunities for Immunocore Holdings and Akero Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Immunocore and Akero is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Immunocore Holdings and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Immunocore Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunocore Holdings are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Immunocore Holdings i.e., Immunocore Holdings and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Immunocore Holdings and Akero Therapeutics
Given the investment horizon of 90 days Immunocore Holdings is expected to under-perform the Akero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Immunocore Holdings is 1.47 times less risky than Akero Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Akero Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 2,971 in Akero Therapeutics on August 27, 2024 and sell it today you would earn a total of 302.00 from holding Akero Therapeutics or generate 10.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunocore Holdings vs. Akero Therapeutics
Performance |
| Timeline |
| Immunocore Holdings |
| Akero Therapeutics |
Immunocore Holdings and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunocore Holdings and Akero Therapeutics
The main advantage of trading using opposite Immunocore Holdings and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunocore Holdings position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Immunocore Holdings vs. Arcellx | Immunocore Holdings vs. Ventyx Biosciences | Immunocore Holdings vs. Vaxcyte | Immunocore Holdings vs. Nuvalent |
| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |